Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia

Annals of Epidemiology

Volumn 14, Issue 9, 2004, Pages 669-675

  Hauck, Loran D ^a   Adler, Lee M ^a   Mulla, Zuber D ^a,b  

^a Adventist Health System   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adventist Health System; AHS; Antibiotics; CAP; CI; Cohort Studies; Community acquired Infections; community acquired pneumonia; Critical Pathways; Hospital Costs; Hospital Mortality; Length of Stay; Pneumonia; Retrospective Studies; Severity of Illness Index

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPERIENCE; FEMALE; HEALTH CARE SYSTEM; HEALTH CENTER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; CRITICAL PATHWAYS; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HOSPITALS, RELIGIOUS; HUMANS; MALE; MIDDLE AGED; MULTI-INSTITUTIONAL SYSTEMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PNEUMONIA; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 4544349752     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2004.01.003     Document Type: Article

References (16)

1. Minino A.M., Arias E., Kochanek K.D., Murphy S.L., Smith B.L. Deaths: Final Data for 2000. National Vital Statistics Reports. Vol. 50, No. 15. 2002;National Center for Health Statistics, Hyattsville, MD
2. Hall M.J., Owings M.F. 2000 National Hospital Discharge Survey. Advance Data from Vital and Health Statistics. No. 329. 2002;National Center for Health Statistics, Hyattsville, MD
3. Lave J.R., Lin C.J., Fine M.J., Hughes-Cromwick P. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med. 20:1999;189-198
4. Fine M.J., Smith M.A., Carson C.A., Mutha S.S., Sankey S.S., Weissfeld L.A., Kapoor W.N. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA. 257:1996;134-141
5. Mandell L.A., Marrie T.J., Grossman R.E., Chow A.W., Hyland R.H. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian infectious diseases society and the Canadian Thoracic Society. Clin Infect Dis. 31:2000;383-421
6. Bartlett J.G., Dowell S.F., Mandell L.A., File T.M. Jr., Musher D.M., Fine M.J. Infectious diseases society of America guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 31:2000;347-382
7. Niederman M.S., Mandell L.A., Anzueto A., Bass J.B., Broughton W.A., Campbell G.D., et al., American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 163:2001;1730-1754
8. British Thoracic Society. BTS guidelines for the management of community acquired pneumonia in adults. Thorax. 56:(suppl. IV):2001;1-64
9. Nathwani D., Rubenstein E., Barlow G., Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis. 32:2001;728-741
10. Battleman D.S., Callahan M., Thaler H.T. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: Link between quality of care and resource utilization. Arch Intern Med. 162:2002;682-688
11. Marrie T.J., Lau C.Y., Wheeler S.L., Wong C.J., Vandervoort M.K., Feagan B.G. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 283:2000;749-755
12. Szukala M., Lee D. The role of AI in severity adjustment and outcomes assessment. ADVANCE for Health Information Professionals. 6:1996;15-18
13. The SAS Institute. Categorical Data Analysis using Logistic Regression Course Notes. 2000;SAS Institute, Inc, Cary, NC
14. Cole S.R. Analysis of complex survey data using SAS. Comput Methods Programs Biomed. 64:2001;65-69
15. Meehan T.P., Fine M.J., Krumholz H.M., Scinto J.D., Galusha D.H., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 278:1997;2080-2084
16. Benenson R., Magalski A., Cavanaugh S., Williams E. Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality. Acad Emerg Med. 6:1999;1243-1248